MED - Medifast, Inc.
113.00 -0.43 (-0.38%)
After hours: 5:28PM EDT
| Previous Close | 107.85 |
| Open | 111.00 |
| Bid | 108.59 x 800 |
| Ask | 114.00 x 1400 |
| Day's Range | 110.38 - 113.91 |
| 52 Week Range | 49.03 - 142.97 |
| Volume | 212,034 |
| Avg. Volume | 301,565 |
| Market Cap | 1.336B |
| Beta (5Y Monthly) | 0.76 |
| PE Ratio (TTM) | 18.64 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 4.52 (4.24%) |
| Ex-Dividend Date | Mar. 30, 2020 |
| 1y Target Est | N/A |
- Zacks
Zacks.com featured highlights include: BWX Technologies, Murphy USA, Dollar General and Medifast
Zacks.com featured highlights include: BWX Technologies, Murphy USA, Dollar General and Medifast
- Zacks
Surging Earnings Estimates Signal Good News for Medifast (MED)
Medifast (MED) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
- Zacks
4 Top-Ranked Picks Using DuPont Analysis for Solid Returns
Have more faith in DuPont analysis than simple ROE calculation? Bet on these stocks.
- Zacks
4 Top Momentum Stocks Powered by Driehaus Strategy
Investors who have the propensity to take higher risk can think of investing in momentum stocks to boost their gains.
- Zacks
Zacks.com featured highlights include: eXp World, Dropbox, Medifast and Logitech International
Zacks.com featured highlights include: eXp World, Dropbox, Medifast and Logitech International
- Zacks
Are Investors Undervaluing Medifast (MED) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Zacks
Medifast (MED) is an Incredible Growth Stock: 3 Reasons Why
Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Zacks
Consumer Confidence Rebounds in May: 5 Winners
A massive $3 trillion rescue fund, hopes of a COVID-19 vaccine and reopening of businesses are helping consumers regain their lost confidence.
- Thomson Reuters StreetEvents
Edited Transcript of MED earnings conference call or presentation 5-May-20 8:30pm GMT
Q1 2020 Medifast Inc Earnings Call
- Zacks
Why Medifast (MED) Stock Might be a Great Pick
Medifast (MED) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- Zacks
The Zacks Analyst Blog Highlights: Equinox Gold, Medifast, NeoPhotonics, Veritiv and Tutor Perini
The Zacks Analyst Blog Highlights: Equinox Gold, Medifast, NeoPhotonics, Veritiv and Tutor Perini
- Zacks
6 Stocks with Improving Prospects
These 6 stocks are good opportunities, no matter how you look at them.
- Zacks
Zacks.com featured highlights include: NeoPhotonics, eXp World, Cumberland and Medifast
Zacks.com featured highlights include: NeoPhotonics, eXp World, Cumberland and Medifast
- Zacks
Medifast, Inc. (MED) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Medifast, Inc. (MED).
- Zacks
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
- Simply Wall St.
How Does Medifast's (NYSE:MED) P/E Compare To Its Industry, After Its Big Share Price Gain?
Those holding Medifast (NYSE:MED) shares must be pleased that the share price has rebounded 38% in the last thirty...
- Motley Fool
Medifast (MED) Q1 2020 Earnings Call Transcript
On the call with me today are Dan Chard, chief executive officer, and Joe Kelleman, interim chief financial officer. If you've not received the release, it is available on the investor relations portion of Medifast's website at www.medifastinc.com. Before we begin, we'd like to remind everyone that the prepared remarks contain forward-looking statements and management may make additional forward-looking statements in response to your questions.
- Zacks
Medifast (MED) Beats Q1 Earnings and Revenue Estimates
Medifast (MED) delivered earnings and revenue surprises of 46.21% and 10.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Does The Medifast, Inc. (NYSE:MED) Share Price Fall With The Market?
Anyone researching Medifast, Inc. (NYSE:MED) might want to consider the historical volatility of the share price...
